HairCell™ territory license add-on.
License the future of hair regeneration. Lionheart's patented bioelectric platform — clinically validated, FDA-cleared, and recognized with multiple innovation awards — now available for exclusive territories.
The future of hair regeneration.
Existing GetHairMD™ licensees can upgrade their offering with exclusive access to HairCell™, Lionheart's patented, clinically validated bioelectric hair regeneration platform.
If you're not a current GetHairMD™ licensee, contact them directly to acquire the full multi-modality license, which now includes HairCell™.
What's included.
- The HairCell™ Model 240+ stimulator (3-in-1: bioelectric + LED + PEMF)
- Full training & marketing support (includes $5,000 marketing match)
- Starter kit of electrodes, serums, and supplies
- 10-year exclusive territory rights
- Only $19,995 — equipment, license, and support included
Patented bioelectric platform.
- Bioelectric stem cell homing to the scalp
- Expression of COL17A1 — the “Forever Young” collagen protein
- Elasticity improvement + Klotho activation for aging reversal
- Enhanced circulation and inflammation modulation
- Backed by multiple patents and thousands of safe uses with no serious adverse events
Patent Listings · Howard Leonhardt · Eleanor Schuler
16%+ density gain in 4 weeks.
89% success rate across 500+ patients. No serious adverse events. FDA 510(k) cleared.
Proven results.
- +16% hair density in 4 weeks (8 sessions)
- 89% success rate across 500+ patients
- No serious adverse events reported
- Clinics enrolling in South Africa, California, Utah, Arizona, Pennsylvania
- FDA 510(k) cleared via Mettler & ElectroMed OEM devices
Lionheart awards.
AbbVie / Allergan Innovation of the Year
XPrize Healthspan Semi-Finalist
Technology Life Sciences Award Finalist
MedTech Outlook Recognition
Bring HairCell™ to your market.
Join one of the most innovative hair regeneration platforms available today. Our licensing team will follow up within 2 business days with next steps and territory availability.